Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomonitoring measures in relapsing-remitting multiple sclerosis.

Makoto Matsui1, Shin-ich Araya, Hui-Yun Wang

  • 1Department of Neurology and Clinical Research Center, Center for Neurological Diseases, Utano National Hospital, Ukyo, Kyoto 616-8255, Japan. matsuim@utano.hosp.go.jp

Journal of Neuroimmunology
|February 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Ishida et al. Wnt/β-Catenin Signaling Regulates Hepatitis B Virus cccDNA Levels. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 6942.

International journal of molecular sciences·2026
Same author

Retraction: Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.

Oncotarget·2026
Same author

Activin A secretion by muscle-repairing macrophages induces heterotopic ossification in mice.

The Journal of clinical investigation·2026
Same author

Repeated mRNA vaccination and breakthrough infection reveal durable dominance but diminishing recall of vaccine-induced CD8⁺ T-cell clones.

International immunology·2026
Same author

Impact of surface functional group modification on cellular internalization and cytotoxicity of silica nanoparticles.

Particle and fibre toxicology·2025
Same author

Ex vivo lung-organoid model for aberrant basaloid cell induction and activation.

Inflammation and regeneration·2025
Same journal

Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue.

Journal of neuroimmunology·2026
Same journal

Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE).

Journal of neuroimmunology·2026
Same journal

Thymectomy promotes maintained complete stable remission in myasthenia gravis.

Journal of neuroimmunology·2026
Same journal

Spinal cord microglia exhibit a dysfunctional response to myelin damage.

Journal of neuroimmunology·2026
Same journal

Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

Journal of neuroimmunology·2026
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
See all related articles

Immune cell changes in multiple sclerosis (MS) reveal distinct profiles during active and stable stages. Flow cytometry helps assess immune status in MS patients.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Understanding the immune cell dynamics in different MS stages is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate intracellular cytokine profiles and surface phenotypes of circulating lymphocytes in relapsing-remitting multiple sclerosis (MS) patients.
  • To compare immune cell characteristics across active, recovery, and stable MS stages, as well as with healthy controls.

Main Methods:

  • Utilized flow cytometry to analyze intracellular cytokine production (IL-4, IFN-gamma) and surface markers (CD4, CCR4, CD29, CXCR3) on lymphocytes.
  • Examined 45 patients with relapsing-remitting MS at different disease stages and 16 healthy controls.

Related Experiment Videos

Main Results:

  • Patients in the active MS stage showed decreased CD4(+)IL-4(+) Th2 and CD4(+)IFN-gamma(+) Th1 cells compared to stable MS and healthy controls.
  • CCR4(+) Th2 cells were persistently lower in all MS stages compared to controls.
  • CD4(+)CD29(+) and CD4(+)CXCR3(+) cell counts correlated with IFN-gamma-producing cells.

Conclusions:

  • Specific intracellular cytokine profiles and lymphocyte surface phenotypes characterize different stages of relapsing-remitting MS.
  • Flow cytometry provides valuable insights into the current immune status of MS patients.
  • These findings may contribute to a better understanding of MS immunopathogenesis and monitoring.